ArticlePloS one2025
UDP-glucuronic acid availability underlies sex difference in renal expression of nonsulfated Human Natural Killer-1 (HNK-1) glycans.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonsulfated Human Natural Killer-1 (nsHNK-1) glycan is a unique trisaccharide structure terminating in glucuronic acid and synthesized by glucuronyltransferase GlcAT-S. This glycan is specifically expressed in the mouse kidney, particularly in proximal tubules and the thick ascending limb of Henle's loop. Renal nsHNK-1 glycan exhibits an age-dependent increase, indicating that its expression is strictly regulated. However, previous studies have primarily focused on male kidneys, leaving potential sex differences unexplored. In this study, we found that renal nsHNK-1 glycan expression is significantly higher in female mice compared with male mice. Notably, no sex differences were observed in the expression of N-acetyllactosamine structures, the substrate for glucuronic acid modification, or in GlcAT-S expression levels. Moreover, analysis of knockout mice for GlcAT-P, an isoform of GlcAT-S, confirmed that GlcAT-P also does not contribute to the sex differences in nsHNK-1 glycan expression. These findings prompted us to investigate the intracellular availability of uridine diphosphate glucuronic acid (UDP-GlcA), the donor substrate for GlcAT-S, as a possible contributor to sex-specific renal nsHNK-1 glycan expression. To investigate this hypothesis, we developed a quantitative ELISA to measure intracellular UDP-GlcA levels. In vivo, wild-type female mice exhibited lower renal UDP-GlcA levels compared with males. However, this difference was abolished in GlcAT-S knockout mice, suggesting enhanced UDP-GlcA consumption in female mice. In HK-2 cells, derived from human proximal tubular epithelium, cultivation under high-glucose conditions elevated intracellular UDP-GlcA, resulting in increased nsHNK-1 glycan expression. Conversely, stimulation of UDP-GlcA consumption via glucuronidation using 4-methylumbelliferone suppressed the high-glucose-induced increase in nsHNK-1 glycan expression levels. Taken together, these findings identify UDP-GlcA availability as a key determinant of nsHNK-1 glycan biosynthesis in the kidney, highlighting a novel regulatory mechanism that contributes to sex-specific glycan expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.